BALB/c and severe combined immunodeficiency (SCID) mice were inoculated intracerebrally or intraperitoneally with scrapie agent strain ME7 to examine the role of functional lymphocytes and follicular dendritic cells in splenic infectivity and PrP sc accumulation. Intracerebrally inoculated BALB/c and SCID mice developed the clinical signs and microscopic lesions characteristic of scrapie. Spleens from terminally affected BALB/c mice contained PrP s° which was detectable by immunoblot analysis; SCID mouse spleens did not contain detectable PrP so. SCID mouse spleens collected during the first 90 days after intraperitoneal infection contained neither infectivity nor PrP s°.
Sheep scrapie is the archetype of a heterogeneous group of rare transmissible spongiform encephalopathies (TSEs) occurring naturally in humans, cattle, mink, cats and captive deer (Hartsough & Burger, 1965; Williams & Young, 1980; Wells et al., 1987; Leggett et al., 1990; Brown & Gajdusek, 1991) . The histopathological lesions of TSEs are restricted to the nervous system (Chandler, 1969) . However, immunohistochemical and biochemical analyses detect a host cellular membrane glycoprotein, the prion protein (PrP c) (Prusiner, 1982; Oesch et al., 1985; Basler et al., 1986) , that accumulates in lymphoid and nervous tissues as a relatively protease-resistant isoform [PrP s~ in scrapie-infected animals and PrP cJD in Creutzfeldt-Jakob disease (CJD)-infected animals] (Merz et al., 1987; Doi et al., 1988; Farquhar et al., 1989; Kitamoto et al., 1989; . PrP sc is tightly associated with infectivity and may either contain or be the infectious agent itself (Diringer et al., 1983 ; McKinley et al., 1983; Merz et al., 1984 Merz et al., , 1987 . Infectivity and PrP sc accumulation in the spleen are detectable within 2 weeks of experimental infection in rodents and persist throughout the incubation period (Eklund et al., 1967; . Scrapie infectivity in the spleen is associated with post-mitotic non-lymphoid (stromal) cells and is unaffected by thymectomy (McFarlin et al., 1971; Worthington & Clark, 1971 ; Clarke & Kimberlin, 1984; Robinson & Gorham, 1990) . PrP c in normal mouse spleens and prpSc/prP cJD accumulation in infected mouse spleens is restricted to cells with the morphological characteristics and antigen-trapping capacity of follicular dendritic cells (FDCs) (Kitamoto et al., 1991; McBride et al., 1992) . In spite of these similarities, the splenic replication phase is not obligatory in all rodent TSE models. Prion mRNA is detectable in mouse spleens by Northern blot analysis (Caughey et al., 1988) and PrP c is detectable by immunoblot and immunofluorescence analysis of hamster leukocytes and spleens (Bendheim et al., 1992) .
Severe combined immunodeficiency (SCID) mice, which lack functional FDCs secondary to the absence of lymphocytes (Kapasi et al., 1993) , do not develop clinical signs of CJD or accumulation of splenic PrP eJD following intraperitoneal (i.p.) inoculation (Kitamoto et al., 1991) , although CJD is readily transmitted to SCID mice by the intracerebral (i.c.) route. To extend this observation, we have examined splenic infectivity and PrP s° accumulation in SCID mice inoculated with scrapie agent strain ME7.
Homozygous C.B.-17-SCID/SCID female mice, 3 weeks of age, were obtained from Taconic Laboratories and normal 3-week-old female BALB/c mice were obtained from B&K Universal. All mice were housed in groups of two to four animals in microisolator cages and given autoclaved food and water. Scrapie agent strain ME7 was obtained as whole frozen brains from terminally infected C57BL mice. A 10 % (w/v) brain suspension was prepared using sterile Tris-buffered saline (TBS; 0'05 M-Tris-HC1 pH 7'8, 0.1 M-NaC1) in a sterile glass Dounce homogenizer and frozen at -20 °C until required. Mice were inoculated by the i.e. route with 30 gl or by the i.p. route with 100 gl of freshly thawed 10 % brain homogenate or with dilutions made in sterile TBS. Controls included untreated mice and mice inoculated with similar volumes of a 10% homogenate of uninfected C57BL brain or with TBS alone. Mice were 0001-2261 © 1994 SGM observed daily for clinical signs (ruffled fur, lethargy, ataxia) and euthanized either when clearly moribund or 3 weeks after lethargy was first noted. Incubation times are reported as days from inoculation to euthanasia or death. The i.c. infectious titre of the inoculum was 109LDs0/ml (Reed & Muench, 1938; Eklund et al., 1967) . Inoculation (i.c.) of SCID mice with the five lowest dilutions of the inoculum resulted in incubation periods (Table 1 ) similar to those observed in BALB/c mice. Histopathological examination of the brains of representative affected BALB/c and SCID mice showed focal spongiosis, astrocytosis and rare intraneuronal vacuolation (not shown). Infectivity in the spleens of i.p.-inoculated SCID and BALB/c mice was determined at 30, 60 and 90 days postinoculation (p.i.). Spleens were collected from individual ME7-infected BALB/c or SCID mice and from uninfected control mice. All mice were clinically normal when tissues were collected. Homogenates (10% w/v) were prepared with sterile TBS in disposable tissue homogenizers, clarified at 228g for 10 rain at 4 °C, and the supernatants were kept at -20 °C until used. Freshly thawed suspensions were briefly clarified at 11000 g at 4 °C and bioassayed by i.c. inoculation in groups of four weanling BALB/c mice per donor spleen. Bioassay recipient mice were observed daily beginning at 112 days p.i. for clinical signs of scrapie and surviving animals were observed for 360 days. Tissues from representative animals were examined for lesions to confirm the clinical diagnosis.
Infectivity was detectable in all spleens collected from ME7-inoculated BALB/c mice. Mean incubation times for recipients of spleens collected at 30, 60 and 90 days p.i. were 187, 168 and 184 days respectively (Table 2) , consistent with the observation that splenic infectivity levels reach a plateau within 2 months following subcutaneous (Eklund et al., 1967) or i.c. inoculation . Recipients of inocula from the spleens of ME7-inoculated SCID mice were clinically normal throughout the 360 day observation period. Recipients of inocula from the spleens of uninoculated BALB/c and SCID mice also remained clinically normal. These observations demonstrate that scrapie infectivity, as defined by mouse subinoculation, was not detectable in the spleens of scrapie-inoculated SCID mice during the first 90 days p.i.
PrP s° accumulation was monitored by immunoblot analysis of tissues using the procedure described by with slight modifications. Brains and spleens were collected from i.c. inoculated mice when they were terminally affected and from clinically normal, i.p. inoculated mice at 60 days p.i. Brains from individual mice or 200 to 250 mg aliquots of spleens from groups of three mice were prepared as 10 % (w/v) homogenates in sterile 0.01 M-Tris-HCI pH 7.5, 0.005M-MgC12 using disposable homogenizers, digested with DNase (final concentration 1 U/ml) for 1 h at 37 °C, and kept at -20 °C until assayed. Samples were adjusted to 10% Sarkosyl, clarified at 10000g for 30 min at 20 °C and pelleted at 215000g for 2h at 4°C. Each pellet was resuspended in 1 ml of 0.01 M-Tris-HC1 pH 7.5 and incubated with proteinase K (10 lag per g starting tissue) for 30 rain at 37 °C. The suspension was adjusted to 5 mM-PMSF and centrifuged at 212000 g for 1 h at 4 °C. Pellets were boiled in SDS-PAGE sample buffer (final SDS concentration 5 %) and stored at -20 °C until used for Western immunoblots. PrP s° preparations (representing 1/2 spleen or 1/4 brain per lane) were electrophoresed on 12% polyacrylamide gels (Pharmacia PhastSystem), transferred to PVDF membranes (Immobilon-P, Millipore) and probed with anti-PrP or control rabbit serum. Anti-PrP serum was prepared by inoculation of rabbits with the pentadecapeptide GQGGGTHNQWNKPSK (Shinagawa et al., 1986) synthesized as a multimeric macromolecule on a heptalysine backbone (serum R2843) (Tam, 1988) or covalently coupled to keyhole limpet haemocyanin (serum R27) (Wiley et al., 1987; . Bound rabbit antibody was detected with goat anti-rabbit IgG conjugated to horseradish peroxidase followed by incubation with a chemiluminescent substrate (Amersham) diluted 1:2 in distilled water. Membranes were exposed to ECL Hyperfilm (Amersham) for intervals varying from 5 to 60 s. Both antisera gave comparable staining patterns, although R27 was 50-to 100-fold more sensitive.
PrP s° was detected in the brain but not the spleen of terminally affected, i.c. inoculated SCID mice ( Fig. 1) and in both the brain and spleen of i.c. inoculated BALB/c mice. PrP s° was detected in BALB/c mouse spleen but not in SCID mouse spleen collected 60 days after i.p. inoculation. These findings are consistent with the observation that SCID mouse spleen does not accumulate PrP cJD following either i.c. or i.p. inoculation (Kitamoto et al., 1991) . In that study, PrP cJD was undetectable in the spleen of a SCID mouse collected 500 days after i.p. inoculation.
In this study, we have demonstrated that the scrapie agent does not replicate in the spleens of SCID mice. Furthermore, PrP s~ does not accumulate in SCID mouse spleen following i.p. or i.c. inoculation with the scrapie agent. Failure of SCID mouse spleen to accumulate PrP sc or to harbour infectivity may be due to the lymphocyte deficiency, the failure of FDCs to mature, or to other less well characterized defects in SCID mice. Immunohistochemical evidence for PrP c and prpSc/ PrP cJD in FDCs is consistent with early experiments using cyclophosphamide-treated mice, which suggested that the tissue-associated non-mitotic cells (Worthington & Clark, 1971) , rather than the circulating lymphocytes, are the site of agent replication.
The association of the scrapie agent with antigentrapping cells such as FDCs is of interest because the agent may replicate in that cell type or it may accumulate there after replication in other tissues and transport via the peripheral circulation (Tenner-Racz et al., 1985; Mori et al., 1991) . Pre-clinical diagnostic testing of sheep by identification of PrP sc in lymphoid tissue has been proposed (Ikegami et al., 1991; Onodera et al., 1993) . The feasibility of such testing increases significantly if a circulating cell type containing infectivity or PrP s~ can be identified. Further discrimination between endogenous and exogenous sources of the FDC-associated scrapie agent will be critical to our understanding of the extraneural pathogenesis of the TSEs.
